ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?

Ranran Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.